| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 233.00K | 202.00K | 1.46M | 3.65M | 3.01M |
| Gross Profit | -321.00K | -576.00K | -13.86M | -5.08M | -630.00K |
| EBITDA | -31.73M | -35.73M | -76.28M | -96.46M | -61.45M |
| Net Income | -33.96M | -35.46M | -87.13M | -98.71M | -65.01M |
Balance Sheet | |||||
| Total Assets | 90.89M | 27.12M | 54.32M | 133.34M | 186.15M |
| Cash, Cash Equivalents and Short-Term Investments | 86.46M | 22.28M | 36.52M | 94.20M | 164.01M |
| Total Debt | 235.00K | 4.21M | 17.27M | 27.73M | 0.00 |
| Total Liabilities | 9.55M | 12.00M | 25.29M | 39.37M | 17.39M |
| Stockholders Equity | 81.34M | 15.12M | 29.02M | 93.97M | 168.77M |
Cash Flow | |||||
| Free Cash Flow | -27.89M | -27.11M | -52.68M | -75.85M | -56.72M |
| Operating Cash Flow | -27.78M | -26.62M | -50.73M | -71.65M | -55.70M |
| Investing Cash Flow | -30.80M | 7.74M | 55.35M | 68.46M | -151.55M |
| Financing Cash Flow | 91.67M | 10.06M | -6.76M | 8.07M | 207.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $3.59B | 26.76 | 8.00% | ― | 43.16% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | $101.57M | -12.53 | -72.75% | ― | -19.11% | 73.51% | |
52 Neutral | $356.75M | -8.83 | 13.96% | ― | 6.59% | 55.85% | |
48 Neutral | $847.73M | -5.21 | 9999.00% | ― | 89.90% | 5.13% | |
47 Neutral | $148.02M | -2.52 | -73.64% | ― | 46.09% | 46.01% |
On February 9, 2026, AEye’s compensation committee approved new standard cash-settled grant agreements for performance stock units and restricted stock units under its 2021 Equity Incentive Plan, formalizing updated instruments for equity and cash-based incentives. These agreements allow settlement in cash if insufficient shares are available, aligning compensation flexibility with the company’s capital structure.
On February 9, 2026, AEye granted performance stock units to its general counsel and chief financial officer, followed by a February 11, 2026 grant to its chief executive officer, all vesting in thirds upon the stock sustaining price milestones of $3, $4, and $5 over five consecutive trading days. The structure ties executive rewards to meaningful share price appreciation by December 31, 2030, potentially sharpening management’s focus on long-term market performance while exposing executives’ compensation to equity market risk.
The most recent analyst rating on (LIDR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on AEye Inc stock, see the LIDR Stock Forecast page.